Dr. Reddy's Laboratories, Inc. recalls Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laborat…
- Recall date
- November 7, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0283-2019
- FDA classification
- Class II
- Brand / firm
- Dr. Reddy's Laboratories, Inc.
- Sold / distributed
- U.S.A.nationwide
Why it was recalled
Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Srikakulam - 532 409, India, NDC 55111-671-31
Get recall alerts
Free email alert whenever Dr. Reddy's Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Dr. Reddy's Laboratories, Inc.